Equities analysts expect that Nu Skin Enterprises, Inc. (NYSE:NUS) will announce $0.90 earnings per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Nu Skin Enterprises’ earnings, with estimates ranging from $0.85 to $0.92. Nu Skin Enterprises posted earnings of $0.77 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 16.9%. The firm is scheduled to issue its next quarterly earnings results on Wednesday, November 7th.

According to Zacks, analysts expect that Nu Skin Enterprises will report full-year earnings of $3.61 per share for the current year, with EPS estimates ranging from $3.59 to $3.65. For the next year, analysts expect that the company will report earnings of $4.08 per share, with EPS estimates ranging from $3.76 to $4.54. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that cover Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $1.08 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.18. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. The business had revenue of $704.19 million during the quarter, compared to analysts’ expectations of $642.16 million. During the same period last year, the company posted $0.77 EPS. The business’s revenue was up 28.0% on a year-over-year basis.

NUS has been the subject of a number of recent research reports. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, June 12th. Jefferies Financial Group reissued a “buy” rating and issued a $98.00 price objective on shares of Nu Skin Enterprises in a research note on Tuesday, September 4th. ValuEngine cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 6th. Finally, Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $57.00 to $70.00 in a research note on Thursday, August 2nd. They noted that the move was a valuation call. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $85.33.

In related news, insider Joseph Y. Chang sold 10,600 shares of Nu Skin Enterprises stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $82.13, for a total transaction of $870,578.00. Following the completion of the transaction, the insider now directly owns 63,416 shares of the company’s stock, valued at approximately $5,208,356.08. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, General Counsel D Matthew Dorny sold 2,500 shares of Nu Skin Enterprises stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $79.90, for a total transaction of $199,750.00. Following the transaction, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,706,292.90. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,850 shares of company stock valued at $3,589,888. 3.00% of the stock is owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the stock. Global X Management Co LLC lifted its holdings in Nu Skin Enterprises by 141.9% during the 2nd quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock valued at $135,000 after buying an additional 1,016 shares in the last quarter. Quantbot Technologies LP lifted its holdings in Nu Skin Enterprises by 293.0% during the 1st quarter. Quantbot Technologies LP now owns 2,071 shares of the company’s stock valued at $152,000 after buying an additional 1,544 shares in the last quarter. Oppenheimer Asset Management Inc. bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at about $210,000. Greenleaf Trust bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at about $216,000. Finally, Stevens Capital Management LP bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at about $221,000. 76.00% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE:NUS traded up $0.67 on Friday, reaching $82.49. The company’s stock had a trading volume of 7,908 shares, compared to its average volume of 352,281. Nu Skin Enterprises has a 52-week low of $59.31 and a 52-week high of $88.68. The stock has a market capitalization of $4.75 billion, a P/E ratio of 25.55, a PEG ratio of 2.44 and a beta of 1.11. The company has a quick ratio of 1.19, a current ratio of 1.82 and a debt-to-equity ratio of 0.46.

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 12th. Investors of record on Friday, August 31st were paid a dividend of $0.365 per share. The ex-dividend date of this dividend was Thursday, August 30th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.77%. Nu Skin Enterprises’s dividend payout ratio is presently 45.20%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Featured Article: Buyback

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.